Romania Bioinformatics Market Analysis Report [2022-30] I Insights10

Romania Bioinformatics Market Analysis

$ 3999

The Romania Bioinformatics market is projected to grow from $44.52 Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The main factors driving the growth would be advancements in genomics and bioinformatics technologies and growing interest in personalized medicine. The market is segmented by technology and by application. Some of the major players include Agilent Technologies, IBM Life Sciences, Eurofins Scientific, and Smedix.

ID: IN10ROHS001 CATEGORY: Healthcare Services GEOGRAPHY: Romania AUTHOR: Neha Davda

Buy Now

Romania Bioinformatics Market Executive Summary

The Romania Bioinformatics market is projected to grow from $44.52 Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. In 2019, national healthcare spending in Romania as a percentage of GDP reached 5.74% achieving $739 per capita from $5.56% or $687 per capita in 2018. Despite an improvement in the past ten years, Romania's health spending per person and as a percentage of GDP is still the second lowest in the EU.

Bioinformatics is a branch of biology that integrates with information technology. Data generation, data warehousing, data mining, data management, and other methods are used in bioinformatics. Bioinformatics software and tools are used as integrated solutions to provide statistical techniques and data processing algorithms for applications such as next-generation sequencing, modeling of genomic and proteomic structure, and three-dimensional drug discovery. Romania's bioinformatics market is still quite modest in comparison to other European nations, but it is anticipated to expand during the next few years.

Romania bioinformatics market analysis

Market Dynamics

Market Growth Drivers

The Romania bioinformatics market is expected to be driven by factors such as advancements in genomics and bioinformatics technologies and growing interest in personalized medicine. Additionally, a growing number of research institutions in Romania, and these institutions are actively engaged in the creation of new technologies. The bioinformatics market is anticipated to rise as a result of these developments.

Market Restraints

Romania's bioinformatics market is relatively small compared to those in other European and North American nations. As market size can influence the amount of investment and the number of businesses in a certain industry, this may limit the market's potential for expansion. Further, as bioinformatics is a highly competitive market, companies may face difficulty in accessing funding.

Competitive Landscape

Key Players

Agilent Technologies
IBM Life Sciences
Eurofins Scientific
Smedix

Healthcare Policies and Regulatory Landscape

Romania's healthcare system is founded on a public-private partnership, with the government providing the majority share of funding. The country's healthcare policies and regulations are developed and implemented by the Ministry of Health.

The National Health Insurance Fund (CNAS) in Romania offers citizens access to universal healthcare coverage. The CNAS is in charge of overseeing the healthcare industry and paying medical professionals for the services they render. The major laws governing medical devices and drugs in Romania are the Pharmaceutical Law and the Law on Medical Devices. These regulations specify the criteria for the nation's registration, assessment, and oversight of pharmaceuticals and medical devices. Additionally, as a member of the European Union, Romania is required to abide by all EU healthcare rules, such as the EU Medical Devices Regulation and the EU In-Vitro Diagnostics Regulation.

Reimbursement Scenario

The National Health Insurance Fund (CNAS), which is in charge of overseeing the healthcare system and compensating healthcare providers for the services they render, sets reimbursement regulations in Romania. Based on the cost of the treatment and the anticipated clinical outcomes, the CNAS establishes reimbursement rates for various healthcare services.

In Romania, the mandatory health insurance program, which is funded by payroll taxes and employee and employer contributions, provides reimbursement for medical services. The mandated health insurance system in Romania provides residents with access to a comprehensive range of healthcare services, including inpatient and outpatient care, prescription medications, and diagnostic tests.

Healthcare providers bill the CNAS directly for the services they provide, and the payment procedure is based on a fee-for-service approach. The providers are subsequently paid by the CNAS according to the fees that have been established for each service.

1. Executive Summary
1.1 Service Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Healthcare Services Market in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Services
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Bioinformatics Market Segmentation

By Technology (Revenue, USD Billion):

Knowledge Management Tools
Bioinformatics Platforms
Bioinformatics Services

By Application (Revenue, USD Billion):

Metabolomics
Molecular phylogenetics
Transcriptomics
Chemoinformatic & drug design
Genomics
Others

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.